IL10 and Sepsis: MSCs have an immunomodulatory effect when used in the pro-inflammatory phase of sepsis, increasing the phagocytic capacity of immune cells [8] and causing macrophages of septic mice to produce more IL-10, shifting to a more anti-inflammatory phenotype, as well as improving organ function, which promotes a higher rate of survival [22].